• About us
• Contact

Advertisement

Product › Details

secukinumab (AIN457)

	Next higher product group	anti-inflammatory drug_o
	Status	2014-12-26 registration start
	Organisation	Novartis AG (NYSE: NVS)
	Group	Novartis (Group)

Record changed: 2023-07-10

Advertisement

More documents for secukinumab (AIN457)

• [1] MoonLake Immunotherapeutics AG. (5/6/21). "Press Release: MoonLake Immunotherapeutics Announces Publication in The Lancet". Zug....
• [2] Novartis AG. (7/19/19). "Press Release: Novartis Key Multiple Sclerosis Product Gilenya Approved in China". Basel....
• [3] Novartis AG. (4/2/19). "Press Release: Novartis First-in-class Cosentyx Approved in China for Psoriasis Patients". Basel....
• [4] Novartis AG. (10/18/18). "Press Release: Novartis Delivered Strong Growth and Innovation During the Third Quarter, Including Progressing Advanced Therapy Platforms to Drive Future growth". Basel....
• [5] Novartis AG. (1/24/18). "Press Release: Novartis Delivered Good Operational Performance and Landmark Innovation in 2017, Entering Our Next Growth Phase". Basel....
• [6] Novartis AG. (1/16/18). "Press Release: Novartis New Data Reinforces Superiority of Cosentyx versus Stelara in Achieving Skin Clearance for Psoriasis Patients". Basel....
• [7] Novartis AG. (10/30/17). "Press Release: Novartis to Present First of its Kind Evidence for Cosentyx on Potential to Maintain Mobility in Patients with AS and PsA". Basel....
• [8] Novartis AG. (7/14/17). "Press Release: Novartis Confirms 5 Year Data for First and Only Fully-human IL-17A Inhibitor Cosentyx Reinforcing Sustained Efficacy and Safety Profile in Psoriasis". Basel....
• [9] Novartis AG. (3/6/17). "Press Release: Novartis' Cosentyx Shows Almost All Psoriasis Patients Rapidly Regain Skin Clearance Following a Treatment Pause". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.